Novelix Pharmaceuticals Peer Comparison

Novelix Pharmaceuticals Ltd. significantly underperforms compared to its peers across all key metrics. With negative growth, high valuation ratios, and low profitability, it presents a concerning picture for investors. In contrast, Adani Enterprises and Redington stand out as strong performers in terms of growth and profitability.

• • Novelix Pharmaceuticals shows negative revenue growth and EPS, indicating poor performance.
• • Adani Enterprises and Redington show strong revenue growth and profitability metrics.
• • High PE ratios across the board suggest overvaluation, especially for Novelix.
• • Companies like MMTC and Honasa are financially weak with negative EPS and cash flow concerns.

• • Adani Enterprises Ltd.: Strong revenue growth (1.53% YoY), low PE of 43.53, and solid ROE of 9.48%
• • Redington Ltd.: Highest revenue growth (12.56% YoY), solid profitability with ROE of 17.12% and low PE of 13.20